Ipsen
The Director of Epidemiology & RWE Sciences at Ipsen leads global evidence strategies for rare disease assets, overseeing the design and execution of real-world evidence studies across the product lifecycle. This role involves partnering with cross-functional teams to generate robust data supporting regulatory, payer, and clinical decision-making while mentoring staff and developing scientific methodologies. The position requires significant expertise in pharmaco-epidemiology and advanced analytics to address high unmet medical needs in rare indications.
Headquarters
Paris, Île-De-France, France
Company Size
5001-10000 employees
Founded
1929
Ipsen is a global biopharmaceutical company focused on innovation and specialty care to improve the lives of patients around the world.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Ipsen.
23% above the average for this role
IPSEN (OTCMKTS:IPSEY) Stock Crosses Above Two Hundred Day Moving Average - Here's What Happened
9 hours ago
Real-World Evidence (RWE) Scientific Lead
sanofi us
Senior Director, Epidemiology, Immunology
Celldex Therapeutics
Senior Director, Respiratory Innovation, VID Global Epidemiology & RWE
GSK plc
Senior Real World Evidence Expert
UCB
Senior Real World Evidence Expert
UCB
Senior Director, Epidemiology
AstraZeneca